{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T21:53:33Z","timestamp":1794434013564,"version":"4.9.1"},"reference-count":235,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T00:00:00Z","timestamp":1704758400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T00:00:00Z","timestamp":1704758400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82001128"],"award-info":[{"award-number":["82001128"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81970993"],"award-info":[{"award-number":["81970993"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271449"],"award-info":[{"award-number":["82271449"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["2021J01672"],"award-info":[{"award-number":["2021J01672"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Neurodegener"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Alzheimer\u2019s disease (AD) is the most prevalent form of dementia in the elderly and represents a major clinical challenge in the ageing society. Neuropathological hallmarks of AD include neurofibrillary tangles composed of hyperphosphorylated tau, senile plaques derived from the deposition of amyloid-\u03b2 (A\u03b2) peptides, brain atrophy induced by neuronal loss, and synaptic dysfunctions. Death-associated protein kinase 1 (DAPK1) is ubiquitously expressed in the central nervous system. Dysregulation of DAPK1 has been shown to contribute to various neurological diseases including AD, ischemic stroke and Parkinson\u2019s disease (PD). We have established an upstream effect of DAPK1 on A\u03b2 and tau pathologies and neuronal apoptosis through\u00a0kinase-mediated protein phosphorylation, supporting a causal role of DAPK1 in the pathophysiology of AD. In this review, we summarize current knowledge about how DAPK1 is involved in various AD pathological changes including tau hyperphosphorylation, A\u03b2 deposition, neuronal cell death and synaptic degeneration. The underlying molecular mechanisms of DAPK1 dysregulation in AD are discussed. We also review the recent progress regarding the development of novel DAPK1 modulators and their potential applications in AD intervention. These findings substantiate DAPK1 as a novel therapeutic target for the development of multifunctional disease-modifying treatments for AD and other neurological disorders.<\/jats:p>","DOI":"10.1186\/s40035-023-00395-5","type":"journal-article","created":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T03:02:39Z","timestamp":1704769359000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Death-associated protein kinase 1 as a therapeutic target for Alzheimer's disease"],"prefix":"10.1186","volume":"13","author":[{"given":"Tao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byeong Mo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5968-1478","authenticated-orcid":false,"given":"Tae Ho","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,9]]},"reference":[{"issue":"2","key":"395_CR1","doi-asserted-by":"publisher","first-page":"e105","DOI":"10.1016\/S2468-2667(21)00249-8","volume":"7","author":"E Nichols","year":"2022","unstructured":"Nichols E, Steinmetz JD, Vollset SE, Fukutaki K, Chalek J, Abd-Allah F, et al. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the global burden of disease study 2019. Lancet Public Health. 2022;7(2):e105\u201325.","journal-title":"Lancet Public Health"},{"key":"395_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101337","volume":"45","author":"PP Velandia","year":"2022","unstructured":"Velandia PP, Miller-Petrie MK, Chen C, Chakrabarti S, Chapin A, Hay S, et al. Global and regional spending on dementia care from 2000\u20132019 and expected future health spending scenarios from 2020\u20132050: an economic modelling exercise. EClinicalMedicine. 2022;45: 101337.","journal-title":"EClinicalMedicine"},{"key":"395_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.conb.2022.102575","volume":"75","author":"A Mangalmurti","year":"2022","unstructured":"Mangalmurti A, Lukens JR. How neurons die in Alzheimer\u2019s disease: implications for neuroinflammation. Curr Opin Neurobiol. 2022;75: 102575.","journal-title":"Curr Opin Neurobiol"},{"issue":"1","key":"395_CR4","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.arr.2012.06.003","volume":"12","author":"L Martin","year":"2013","unstructured":"Martin L, Latypova X, Wilson CM, Magnaudeix A, Perrin ML, Yardin C, et al. Tau protein kinases: involvement in Alzheimer\u2019s disease. Ageing Res Rev. 2013;12(1):289\u2013309.","journal-title":"Ageing Res Rev"},{"issue":"1","key":"395_CR5","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.arr.2012.06.008","volume":"12","author":"L Martin","year":"2013","unstructured":"Martin L, Latypova X, Wilson CM, Magnaudeix A, Perrin ML, Terro F. Tau protein phosphatases in Alzheimer\u2019s disease: the leading role of PP2A. Ageing Res Rev. 2013;12(1):39\u201349.","journal-title":"Ageing Res Rev"},{"issue":"2","key":"395_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagen.2022.130276","volume":"1867","author":"TG Castro","year":"2023","unstructured":"Castro TG, Ferreira T, Matama T, Munteanu FD, Cavaco-Paulo A. Acetylation and phosphorylation processes modulate Tau\u2019s binding to microtubules: a molecular dynamics study. Biochim Biophys Acta Gen Subj. 2023;1867(2): 130276.","journal-title":"Biochim Biophys Acta Gen Subj"},{"issue":"1","key":"395_CR7","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13024-021-00460-5","volume":"16","author":"Y Xia","year":"2021","unstructured":"Xia Y, Prokop S, Giasson BI. \u201cDon\u2019t Phos Over Tau\u201d: recent developments in clinical biomarkers and therapies targeting tau phosphorylation in Alzheimer\u2019s disease and other tauopathies. Mol Neurodegener. 2021;16(1):37.","journal-title":"Mol Neurodegener"},{"issue":"1","key":"395_CR8","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s40478-022-01394-9","volume":"10","author":"G Paterno","year":"2022","unstructured":"Paterno G, Bell BM, Gorion KM, Prokop S, Giasson BI. Reassessment of neuronal tau distribution in adult human brain and implications for tau pathobiology. Acta Neuropathol Commun. 2022;10(1):94.","journal-title":"Acta Neuropathol Commun"},{"issue":"9","key":"395_CR9","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1021\/acschemneuro.1c00084","volume":"12","author":"L Rani","year":"2021","unstructured":"Rani L, Mallajosyula SS. Phosphorylation-induced structural reorganization in tau-paired helical filaments. ACS Chem Neurosci. 2021;12(9):1621\u201331.","journal-title":"ACS Chem Neurosci"},{"key":"395_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.590754","volume":"11","author":"SS Oakley","year":"2020","unstructured":"Oakley SS, Maina MB, Marshall KE, Al-Hilaly YK, Harrington CR, Wischik CM, et al. Tau filament self-assembly and structure: tau as a therapeutic target. Front Neurol. 2020;11: 590754.","journal-title":"Front Neurol"},{"issue":"5","key":"395_CR11","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s00401-018-1914-z","volume":"136","author":"B Falcon","year":"2018","unstructured":"Falcon B, Zhang W, Schweighauser M, Murzin AG, Vidal R, Garringer HJ, et al. Tau filaments from multiple cases of sporadic and inherited Alzheimer\u2019s disease adopt a common fold. Acta Neuropathol. 2018;136(5):699\u2013708.","journal-title":"Acta Neuropathol"},{"issue":"5","key":"395_CR12","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1097\/NEN.0b013e31825018f7","volume":"71","author":"PT Nelson","year":"2012","unstructured":"Nelson PT, Alafuzoff I, Bigio EH, Bouras C, Braak H, Cairns NJ, et al. Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature. J Neuropathol Exp Neurol. 2012;71(5):362\u201381.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"338","key":"395_CR13","doi-asserted-by":"publisher","first-page":"338ra366","DOI":"10.1126\/scitranslmed.aaf2362","volume":"8","author":"MR Brier","year":"2016","unstructured":"Brier MR, Gordon B, Friedrichsen K, McCarthy J, Stern A, Christensen J, et al. Tau and Abeta imaging, CSF measures, and cognition in Alzheimer\u2019s disease. Sci Transl Med. 2016;8(338):338ra366.","journal-title":"Sci Transl Med."},{"issue":"Pt 5","key":"395_CR14","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1093\/brain\/aww027","volume":"139","author":"R Ossenkoppele","year":"2016","unstructured":"Ossenkoppele R, Schonhaut DR, Scholl M, Lockhart SN, Ayakta N, Baker SL, et al. Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer\u2019s disease. Brain. 2016;139(Pt 5):1551\u201367.","journal-title":"Brain"},{"issue":"2","key":"395_CR15","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41582-018-0116-6","volume":"15","author":"F Panza","year":"2019","unstructured":"Panza F, Lozupone M, Logroscino G, Imbimbo BP. A critical appraisal of amyloid-beta-targeting therapies for Alzheimer disease. Nat Rev Neurol. 2019;15(2):73\u201388.","journal-title":"Nat Rev Neurol"},{"key":"395_CR16","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1146\/annurev-neuro-061010-113613","volume":"34","author":"RJ O'Brien","year":"2011","unstructured":"O\u2019Brien RJ, Wong PC. Amyloid precursor protein processing and Alzheimer\u2019s disease. Annu Rev Neurosci. 2011;34:185\u2013204.","journal-title":"Annu Rev Neurosci"},{"issue":"suppl1","key":"395_CR17","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.1471-4159.2011.07519.x","volume":"120","author":"H Zhang","year":"2012","unstructured":"Zhang H, Ma Q, Zhang YW, Xu H. Proteolytic processing of Alzheimer\u2019s beta-amyloid precursor protein. J Neurochem. 2012;120(suppl1):9\u201321.","journal-title":"J Neurochem"},{"issue":"5","key":"395_CR18","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/nrn.2017.29","volume":"18","author":"UC Muller","year":"2017","unstructured":"Muller UC, Deller T, Korte M. Not just amyloid: physiological functions of the amyloid precursor protein family. Nat Rev Neurosci. 2017;18(5):281\u201398.","journal-title":"Nat Rev Neurosci"},{"issue":"44","key":"395_CR19","doi-asserted-by":"publisher","first-page":"29615","DOI":"10.1074\/jbc.R800019200","volume":"283","author":"G Thinakaran","year":"2008","unstructured":"Thinakaran G, Koo EH. Amyloid precursor protein trafficking, processing, and function. J Biol Chem. 2008;283(44):29615\u20139.","journal-title":"J Biol Chem"},{"key":"395_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2019.172415","volume":"856","author":"M Yuksel","year":"2019","unstructured":"Yuksel M, Tacal O. Trafficking and proteolytic processing of amyloid precursor protein and secretases in Alzheimer\u2019s disease development: an up-to-date review. Eur J Pharmacol. 2019;856: 172415.","journal-title":"Eur J Pharmacol"},{"issue":"9","key":"395_CR21","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1038\/aps.2017.28","volume":"38","author":"GF Chen","year":"2017","unstructured":"Chen GF, Xu TH, Yan Y, Zhou YR, Jiang Y, Melcher K, et al. Amyloid beta: structure, biology and structure-based therapeutic development. Acta Pharmacol Sin. 2017;38(9):1205\u201335.","journal-title":"Acta Pharmacol Sin"},{"issue":"5","key":"395_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2022.100630","volume":"3","author":"B Kass","year":"2022","unstructured":"Kass B, Schemmert S, Zafiu C, Pils M, Bannach O, Kutzsche J, et al. Abeta oligomer concentration in mouse and human brain and its drug-induced reduction ex vivo. Cell Rep Med. 2022;3(5): 100630.","journal-title":"Cell Rep Med"},{"issue":"7","key":"395_CR23","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1002\/psc.2789","volume":"21","author":"T Qiu","year":"2015","unstructured":"Qiu T, Liu Q, Chen YX, Zhao YF, Li YM. Abeta42 and Abeta40: similarities and differences. J Pept Sci. 2015;21(7):522\u20139.","journal-title":"J Pept Sci"},{"issue":"10","key":"395_CR24","doi-asserted-by":"publisher","first-page":"5481","DOI":"10.1038\/s41380-021-01249-0","volume":"26","author":"H Hampel","year":"2021","unstructured":"Hampel H, Hardy J, Blennow K, Chen C, Perry G, Kim SH, et al. The amyloid-beta pathway in Alzheimer\u2019s Disease. Mol Psychiatry. 2021;26(10):5481\u2013503.","journal-title":"Mol Psychiatry"},{"issue":"2","key":"395_CR25","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1001\/archneurol.2007.57","volume":"65","author":"J Sundelof","year":"2008","unstructured":"Sundelof J, Giedraitis V, Irizarry MC, Sundstrom J, Ingelsson E, Ronnemaa E, et al. Plasma beta amyloid and the risk of Alzheimer disease and dementia in elderly men: a prospective, population-based cohort study. Arch Neurol. 2008;65(2):256\u201363.","journal-title":"Arch Neurol"},{"issue":"4","key":"395_CR26","doi-asserted-by":"publisher","first-page":"E476","DOI":"10.1073\/pnas.1618657114","volume":"114","author":"L Sun","year":"2017","unstructured":"Sun L, Zhou R, Yang G, Shi Y. Analysis of 138 pathogenic mutations in presenilin-1 on the in vitro production of Abeta42 and Abeta40 peptides by gamma-secretase. Proc Natl Acad Sci U S A. 2017;114(4):E476\u201385.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"395_CR27","doi-asserted-by":"publisher","first-page":"e35807","DOI":"10.1371\/journal.pone.0035807","volume":"7","author":"WT Chen","year":"2012","unstructured":"Chen WT, Hong CJ, Lin YT, Chang WH, Huang HT, Liao JY, et al. Amyloid-beta (Abeta) D7H mutation increases oligomeric Abeta42 and alters properties of Abeta-zinc\/copper assemblies. PLoS ONE. 2012;7(4):e35807.","journal-title":"PLoS ONE"},{"issue":"1","key":"395_CR28","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s42003-023-04539-1","volume":"6","author":"HN Do","year":"2023","unstructured":"Do HN, Devkota S, Bhattarai A, Wolfe MS, Miao Y. Effects of presenilin-1 familial Alzheimer\u2019s disease mutations on gamma-secretase activation for cleavage of amyloid precursor protein. Commun Biol. 2023;6(1):174.","journal-title":"Commun Biol"},{"key":"395_CR29","doi-asserted-by":"publisher","first-page":"695808","DOI":"10.3389\/fnagi.2021.695808","volume":"13","author":"X Xiao","year":"2021","unstructured":"Xiao X, Liu H, Liu X, Zhang W, Zhang S, Jiao B. APP, PSEN1, and PSEN2 variants in Alzheimer\u2019s disease: systematic re-evaluation according to ACMG guidelines. Front Aging Neurosci. 2021;13:695808.","journal-title":"Front Aging Neurosci"},{"issue":"6","key":"395_CR30","doi-asserted-by":"publisher","first-page":"a024539","DOI":"10.1101\/cshperspect.a024539","volume":"7","author":"J Tcw","year":"2017","unstructured":"Tcw J, Goate AM. Genetics of beta-Amyloid precursor protein in Alzheimer\u2019s Disease. Cold Spring Harb Perspect Med. 2017;7(6):a024539.","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"4","key":"395_CR31","doi-asserted-by":"publisher","first-page":"313","DOI":"10.2174\/1567205014666170505095109","volume":"15","author":"S Marcelli","year":"2018","unstructured":"Marcelli S, Corbo M, Iannuzzi F, Negri L, Blandini F, Nistico R, et al. The involvement of post-translational modifications in Alzheimer\u2019s disease. Curr Alzheimer Res. 2018;15(4):313\u201335.","journal-title":"Curr Alzheimer Res"},{"issue":"1","key":"395_CR32","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1083\/jcb.200301115","volume":"163","author":"MS Lee","year":"2003","unstructured":"Lee MS, Kao SC, Lemere CA, Xia W, Tseng HC, Zhou Y, et al. APP processing is regulated by cytoplasmic phosphorylation. J Cell Biol. 2003;163(1):83\u201395.","journal-title":"J Cell Biol"},{"issue":"1","key":"395_CR33","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3390\/ijms21010209","volume":"21","author":"T Zhang","year":"2020","unstructured":"Zhang T, Chen D, Lee TH. Phosphorylation signaling in APP processing in Alzheimer\u2019s disease. Int J Mol Sci. 2020;21(1):209.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"395_CR34","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1101\/gad.9.1.15","volume":"9","author":"LP Deiss","year":"1995","unstructured":"Deiss LP, Feinstein E, Berissi H, Cohen O, Kimchi A. Identification of a novel serine\/threonine kinase and a novel 15-kD protein as potential mediators of the gamma interferon-induced cell death. Genes Dev. 1995;9(1):15\u201330.","journal-title":"Genes Dev"},{"issue":"2","key":"395_CR35","doi-asserted-by":"publisher","first-page":"144","DOI":"10.2174\/1574892814666181218170257","volume":"14","author":"D Chen","year":"2019","unstructured":"Chen D, Zhou XZ, Lee TH. Death-associated protein kinase 1 as a promising drug target in cancer and Alzheimer\u2019s disease. Recent Pat Anticancer Drug Discov. 2019;14(2):144\u201357.","journal-title":"Recent Pat Anticancer Drug Discov"},{"issue":"17","key":"395_CR36","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1093\/hmg\/ddl178","volume":"15","author":"Y Li","year":"2006","unstructured":"Li Y, Grupe A, Rowland C, Nowotny P, Kauwe JS, Smemo S, et al. DAPK1 variants are associated with Alzheimer\u2019s disease and allele-specific expression. Hum Mol Genet. 2006;15(17):2560\u20138.","journal-title":"Hum Mol Genet"},{"issue":"1","key":"395_CR37","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3233\/JAD-2012-120520","volume":"32","author":"P Gaj","year":"2012","unstructured":"Gaj P, Paziewska A, Bik W, Dabrowska M, Baranowska-Bik A, Styczynska M, et al. Identification of a late onset Alzheimer\u2019s disease candidate risk variant at 9q21.33 in polish patients. J Alzheimers Dis. 2012;32(1):157\u201368.","journal-title":"J Alzheimers Dis"},{"key":"395_CR38","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.brainres.2010.12.036","volume":"1374","author":"ZC Wu","year":"2011","unstructured":"Wu ZC, Zhang W, Yu JT, Zhang Q, Tian Y, Lu RC, et al. Association of DAPK1 genetic variations with Alzheimer\u2019s disease in Han Chinese. Brain Res. 2011;1374:129\u201333.","journal-title":"Brain Res"},{"issue":"5","key":"395_CR39","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1002\/(SICI)1097-4547(19991201)58:5<674::AID-JNR8>3.0.CO;2-3","volume":"58","author":"M Yamamoto","year":"1999","unstructured":"Yamamoto M, Takahashi H, Nakamura T, Hioki T, Nagayama S, Ooashi N, et al. Developmental changes in distribution of death-associated protein kinase mRNAs. J Neurosci Res. 1999;58(5):674\u201383.","journal-title":"J Neurosci Res"},{"key":"395_CR40","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1146\/annurev.biochem.75.103004.142615","volume":"75","author":"S Bialik","year":"2006","unstructured":"Bialik S, Kimchi A. The death-associated protein kinases: structure, function, and beyond. Annu Rev Biochem. 2006;75:189\u2013210.","journal-title":"Annu Rev Biochem"},{"issue":"1","key":"395_CR41","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/med.21518","volume":"39","author":"AK Farag","year":"2019","unstructured":"Farag AK, Roh EJ. Death-associated protein kinase (DAPK) family modulators: current and future therapeutic outcomes. Med Res Rev. 2019;39(1):349\u201385.","journal-title":"Med Res Rev"},{"issue":"1","key":"395_CR42","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.cellsig.2010.09.016","volume":"23","author":"DH Weitzel","year":"2011","unstructured":"Weitzel DH, Chambers J, Haystead TA. Phosphorylation-dependent control of ZIPK nuclear import is species specific. Cell Signal. 2011;23(1):297\u2013303.","journal-title":"Cell Signal"},{"issue":"44","key":"395_CR43","doi-asserted-by":"publisher","first-page":"29066","DOI":"10.1074\/jbc.273.44.29066","volume":"273","author":"H Sanjo","year":"1998","unstructured":"Sanjo H, Kawai T, Akira S. DRAKs, novel serine\/threonine kinases related to death-associated protein kinase that trigger apoptosis. J Biol Chem. 1998;273(44):29066\u201371.","journal-title":"J Biol Chem"},{"key":"395_CR44","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.biocel.2015.06.001","volume":"65","author":"B Geering","year":"2015","unstructured":"Geering B. Death-associated protein kinase 2: regulator of apoptosis, autophagy and inflammation. Int J Biochem Cell Biol. 2015;65:151\u20134.","journal-title":"Int J Biochem Cell Biol"},{"issue":"42","key":"395_CR45","doi-asserted-by":"publisher","first-page":"38956","DOI":"10.1074\/jbc.M104273200","volume":"276","author":"AV Velentza","year":"2001","unstructured":"Velentza AV, Schumacher AM, Weiss C, Egli M, Watterson DM. A protein kinase associated with apoptosis and tumor suppression: structure, activity, and discovery of peptide substrates. J Biol Chem. 2001;276(42):38956\u201365.","journal-title":"J Biol Chem"},{"issue":"10","key":"395_CR46","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/nsb1001-899","volume":"8","author":"V Tereshko","year":"2001","unstructured":"Tereshko V, Teplova M, Brunzelle J, Watterson DM, Egli M. Crystal structures of the catalytic domain of human protein kinase associated with apoptosis and tumor suppression. Nat Struct Biol. 2001;8(10):899\u2013907.","journal-title":"Nat Struct Biol"},{"key":"395_CR47","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3389\/fnmol.2016.00046","volume":"9","author":"P Singh","year":"2016","unstructured":"Singh P, Ravanan P, Talwar P. Death associated protein kinase 1 (DAPK1): a regulator of apoptosis and autophagy. Front Mol Neurosci. 2016;9:46.","journal-title":"Front Mol Neurosci"},{"issue":"20","key":"395_CR48","doi-asserted-by":"publisher","first-page":"14361","DOI":"10.1074\/jbc.M512613200","volume":"281","author":"A Citri","year":"2006","unstructured":"Citri A, Harari D, Shohat G, Ramakrishnan P, Gan J, Lavi S, et al. Hsp90 recognizes a common surface on client kinases. J Biol Chem. 2006;281(20):14361\u20139.","journal-title":"J Biol Chem"},{"issue":"50","key":"395_CR49","doi-asserted-by":"publisher","first-page":"47460","DOI":"10.1074\/jbc.M105133200","volume":"276","author":"G Shohat","year":"2001","unstructured":"Shohat G, Spivak-Kroizman T, Cohen O, Bialik S, Shani G, Berrisi H, et al. The pro-apoptotic function of death-associated protein kinase is controlled by a unique inhibitory autophosphorylation-based mechanism. J Biol Chem. 2001;276(50):47460\u20137.","journal-title":"J Biol Chem"},{"issue":"7","key":"395_CR50","doi-asserted-by":"publisher","first-page":"13858","DOI":"10.3390\/ijms140713858","volume":"14","author":"S Nair","year":"2013","unstructured":"Nair S, Hagberg H, Krishnamurthy R, Thornton C, Mallard C. Death associated protein kinases: molecular structure and brain injury. Int J Mol Sci. 2013;14(7):13858\u201372.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"395_CR51","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s10495-013-0916-5","volume":"19","author":"J Ivanovska","year":"2014","unstructured":"Ivanovska J, Mahadevan V, Schneider-Stock R. DAPK and cytoskeleton-associated functions. Apoptosis. 2014;19(2):329\u201338.","journal-title":"Apoptosis"},{"issue":"49","key":"395_CR52","doi-asserted-by":"publisher","first-page":"46980","DOI":"10.1074\/jbc.M208585200","volume":"277","author":"Y Jin","year":"2002","unstructured":"Jin Y, Blue EK, Dixon S, Shao Z, Gallagher PJ. A death-associated protein kinase (DAPK)-interacting protein, DIP-1, is an E3 ubiquitin ligase that promotes tumor necrosis factor-induced apoptosis and regulates the cellular levels of DAPK. J Biol Chem. 2002;277(49):46980\u20136.","journal-title":"J Biol Chem"},{"issue":"16","key":"395_CR53","doi-asserted-by":"publisher","first-page":"11795","DOI":"10.1074\/jbc.M610430200","volume":"282","author":"L Zhang","year":"2007","unstructured":"Zhang L, Nephew KP, Gallagher PJ. Regulation of death-associated protein kinase Stabilization by HSP90 heterocomplexes. J Biol Chem. 2007;282(16):11795\u2013804.","journal-title":"J Biol Chem"},{"issue":"5","key":"395_CR54","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.molcel.2007.06.037","volume":"27","author":"WJ Wang","year":"2007","unstructured":"Wang WJ, Kuo JC, Ku W, Lee YR, Lin FC, Chang YL, et al. The tumor suppressor DAPK is reciprocally regulated by tyrosine kinase Src and phosphatase LAR. Mol Cell. 2007;27(5):701\u201316.","journal-title":"Mol Cell"},{"issue":"5","key":"395_CR55","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1042\/BST20120155","volume":"40","author":"S Bialik","year":"2012","unstructured":"Bialik S, Kimchi A. Biochemical and functional characterization of the ROC domain of DAPK establishes a new paradigm of GTP regulation in ROCO proteins. Biochem Soc Trans. 2012;40(5):1052\u20137.","journal-title":"Biochem Soc Trans"},{"issue":"9","key":"395_CR56","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/embor.2011.126","volume":"12","author":"R Carlessi","year":"2011","unstructured":"Carlessi R, Levin-Salomon V, Ciprut S, Bialik S, Berissi H, Albeck S, et al. GTP binding to the ROC domain of DAP-kinase regulates its function through intramolecular signalling. EMBO Rep. 2011;12(9):917\u201323.","journal-title":"EMBO Rep"},{"issue":"2","key":"395_CR57","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.molcel.2011.03.005","volume":"42","author":"TH Lee","year":"2011","unstructured":"Lee TH, Chen CH, Suizu F, Huang P, Schiene-Fischer C, Daum S, et al. Death-associated protein kinase 1 phosphorylates Pin1 and inhibits its prolyl isomerase activity and cellular function. Mol Cell. 2011;42(2):147\u201359.","journal-title":"Mol Cell"},{"issue":"6","key":"395_CR58","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/jnc.15909","volume":"166","author":"R Wang","year":"2023","unstructured":"Wang R, Lu KP, Zhou XZ. Function and regulation of cis P-tau in the pathogenesis and treatment of conventional and nonconventional tauopathies. J Neurochem. 2023;166(6):11.","journal-title":"J Neurochem"},{"issue":"2","key":"395_CR59","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/sj.emboj.7600510","volume":"24","author":"CH Chen","year":"2005","unstructured":"Chen CH, Wang WJ, Kuo JC, Tsai HC, Lin JR, Chang ZF, et al. Bidirectional signals transduced by DAPK-ERK interaction promote the apoptotic effect of DAPK. EMBO J. 2005;24(2):294\u2013304.","journal-title":"EMBO J"},{"issue":"10","key":"395_CR60","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1038\/emboj.2010.62","volume":"29","author":"YR Lee","year":"2010","unstructured":"Lee YR, Yuan WC, Ho HC, Chen CH, Shih HM, Chen RH. The Cullin 3 substrate adaptor KLHL20 mediates DAPK ubiquitination to control interferon responses. EMBO J. 2010;29(10):1748\u201361.","journal-title":"EMBO J"},{"issue":"2","key":"395_CR61","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1111\/j.1742-4658.2010.07959.x","volume":"278","author":"Y Lin","year":"2011","unstructured":"Lin Y, Henderson P, Pettersson S, Satsangi J, Hupp T, Stevens C. Tuberous sclerosis-2 (TSC2) regulates the stability of death-associated protein kinase-1 (DAPK) through a lysosome-dependent degradation pathway. FEBS J. 2011;278(2):354\u201370.","journal-title":"FEBS J"},{"issue":"6","key":"395_CR62","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/onc.2011.264","volume":"31","author":"I Mor","year":"2012","unstructured":"Mor I, Carlessi R, Ast T, Feinstein E, Kimchi A. Death-associated protein kinase increases glycolytic rate through binding and activation of pyruvate kinase. Oncogene. 2012;31(6):683\u201393.","journal-title":"Oncogene"},{"issue":"4","key":"395_CR63","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1073\/pnas.020519497","volume":"97","author":"T Raveh","year":"2000","unstructured":"Raveh T, Berissi H, Eisenstein M, Spivak T, Kimchi A. A functional genetic screen identifies regions at the C-terminal tail and death-domain of death-associated protein kinase that are critical for its proapoptotic activity. Proc Natl Acad Sci U S A. 2000;97(4):1572\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"395_CR64","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1093\/emboj\/16.5.998","volume":"16","author":"O Cohen","year":"1997","unstructured":"Cohen O, Feinstein E, Kimchi A. DAP-kinase is a Ca2+\/calmodulin-dependent, cytoskeletal-associated protein kinase, with cell death-inducing functions that depend on its catalytic activity. EMBO J. 1997;16(5):998\u20131008.","journal-title":"EMBO J"},{"issue":"6","key":"395_CR65","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.12996","volume":"31","author":"I Ferrer","year":"2021","unstructured":"Ferrer I, Andres-Benito P, Ausin K, Pamplona R, Del Rio JA, Fernandez-Irigoyen J, et al. Dysregulated protein phosphorylation: a determining condition in the continuum of brain aging and Alzheimer\u2019s disease. Brain Pathol. 2021;31(6): e12996.","journal-title":"Brain Pathol"},{"issue":"6","key":"395_CR66","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/s43587-021-00071-1","volume":"1","author":"N Morshed","year":"2021","unstructured":"Morshed N, Lee MJ, Rodriguez FH, Lauffenburger DA, Mastroeni D, White FM. Quantitative phosphoproteomics uncovers dysregulated kinase networks in Alzheimer\u2019s disease. Nat Aging. 2021;1(6):550\u201365.","journal-title":"Nat Aging"},{"key":"395_CR67","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/978-1-4939-6952-4_8","volume":"1598","author":"B Bai","year":"2017","unstructured":"Bai B, Tan H, Peng J. Quantitative phosphoproteomic analysis of brain tissues. Methods Mol Biol. 2017;1598:199\u2013211.","journal-title":"Methods Mol Biol"},{"key":"395_CR68","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2021.647451","volume":"14","author":"E Fingleton","year":"2021","unstructured":"Fingleton E, Li Y, Roche KW. Advances in proteomics allow insights into neuronal proteomes. Front Mol Neurosci. 2021;14: 647451.","journal-title":"Front Mol Neurosci"},{"issue":"4","key":"395_CR69","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.devcel.2015.01.019","volume":"32","author":"Y Yamaguchi","year":"2015","unstructured":"Yamaguchi Y, Miura M. Programmed cell death in neurodevelopment. Dev Cell. 2015;32(4):478\u201390.","journal-title":"Dev Cell"},{"key":"395_CR70","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/bs.ctdb.2015.07.016","volume":"114","author":"Y Yamaguchi","year":"2015","unstructured":"Yamaguchi Y, Miura M. Programmed cell death and caspase functions during neural development. Curr Top Dev Biol. 2015;114:159\u201384.","journal-title":"Curr Top Dev Biol"},{"issue":"28","key":"395_CR71","doi-asserted-by":"publisher","first-page":"26265","DOI":"10.1074\/jbc.M300492200","volume":"278","author":"JH Tian","year":"2003","unstructured":"Tian JH, Das S, Sheng ZH. Ca2+-dependent phosphorylation of syntaxin-1A by the death-associated protein (DAP) kinase regulates its interaction with Munc18. J Biol Chem. 2003;278(28):26265\u201374.","journal-title":"J Biol Chem"},{"issue":"5","key":"395_CR72","doi-asserted-by":"publisher","first-page":"106723","DOI":"10.1016\/j.isci.2023.106723","volume":"26","author":"JE Tullis","year":"2023","unstructured":"Tullis JE, Bayer KU. Distinct synaptic pools of DAPK1 differentially regulate activity-dependent synaptic CaMKII accumulation. iScience. 2023;26(5):106723.","journal-title":"iScience."},{"issue":"2","key":"395_CR73","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.cell.2009.12.055","volume":"140","author":"W Tu","year":"2010","unstructured":"Tu W, Xu X, Peng L, Zhong X, Zhang W, Soundarapandian MM, et al. DAPK1 interaction with NMDA receptor NR2B subunits mediates brain damage in stroke. Cell. 2010;140(2):222\u201334.","journal-title":"Cell"},{"issue":"51","key":"395_CR74","doi-asserted-by":"publisher","first-page":"42290","DOI":"10.1074\/jbc.M505804200","volume":"280","author":"M Shamloo","year":"2005","unstructured":"Shamloo M, Soriano L, Wieloch T, Nikolich K, Urfer R, Oksenberg D. Death-associated protein kinase is activated by dephosphorylation in response to cerebral ischemia. J Biol Chem. 2005;280(51):42290\u20139.","journal-title":"J Biol Chem"},{"issue":"6","key":"395_CR75","doi-asserted-by":"publisher","first-page":"4716","DOI":"10.1007\/s12035-016-0008-y","volume":"54","author":"S Wang","year":"2017","unstructured":"Wang S, Shi X, Li H, Pang P, Pei L, Shen H, et al. DAPK1 signaling pathways in stroke: from mechanisms to therapies. Mol Neurobiol. 2017;54(6):4716\u201322.","journal-title":"Mol Neurobiol"},{"issue":"9","key":"395_CR76","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.7150\/ijbs.59922","volume":"17","author":"CL Gan","year":"2021","unstructured":"Gan CL, Zou Y, Xia Y, Zhang T, Chen D, Lan G, et al. Inhibition of death-associated protein kinase 1 protects against epileptic seizures in mice. Int J Biol Sci. 2021;17(9):2356\u201366.","journal-title":"Int J Biol Sci"},{"issue":"12","key":"395_CR77","doi-asserted-by":"publisher","first-page":"6370","DOI":"10.3390\/ijms23126370","volume":"23","author":"CL Gan","year":"2022","unstructured":"Gan CL, Zou Y, Chen D, Shui X, Hu L, Li R, et al. Blocking ERK-DAPK1 axis attenuates glutamate excitotoxicity in epilepsy. Int J Mol Sci. 2022;23(12):6370.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"395_CR78","first-page":"2498","volume":"25","author":"BM Kim","year":"2016","unstructured":"Kim BM, You MH, Chen CH, Suh J, Tanzi RE, Lee TH. Inhibition of death-associated protein kinase 1 attenuates the phosphorylation and amyloidogenic processing of amyloid precursor protein. Hum Mol Genet. 2016;25(12):2498\u2013513.","journal-title":"Hum Mol Genet"},{"issue":"5","key":"395_CR79","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.216","volume":"5","author":"BM Kim","year":"2014","unstructured":"Kim BM, You MH, Chen CH, Lee S, Hong Y, Hong Y, et al. Death-associated protein kinase 1 has a critical role in aberrant tau protein regulation and function. Cell Death Dis. 2014;5(5): e1237.","journal-title":"Cell Death Dis"},{"issue":"24","key":"395_CR80","doi-asserted-by":"publisher","first-page":"3554","DOI":"10.1021\/acschemneuro.2c00423","volume":"13","author":"L Wang","year":"2022","unstructured":"Wang L, Shui X, Zhang M, Mei Y, Xia Y, Lan G, et al. MiR-191-5p attenuates tau phosphorylation, abeta generation, and neuronal cell death by regulating death-associated protein kinase 1. ACS Chem Neurosci. 2022;13(24):3554\u201366.","journal-title":"ACS Chem Neurosci"},{"issue":"14","key":"395_CR81","doi-asserted-by":"publisher","first-page":"7992","DOI":"10.3390\/ijms23147992","volume":"23","author":"L Wang","year":"2022","unstructured":"Wang L, Shui X, Mei Y, Xia Y, Lan G, Hu L, et al. miR-143-3p inhibits aberrant tau phosphorylation and amyloidogenic processing of APP by directly targeting DAPK1 in Alzheimer\u2019s disease. Int J Mol Sci. 2022;23(14):7992.","journal-title":"Int J Mol Sci"},{"issue":"9","key":"395_CR82","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.biopsych.2018.12.008","volume":"85","author":"Y Su","year":"2019","unstructured":"Su Y, Deng MF, Xiong W, Xie AJ, Guo J, Liang ZH, et al. MicroRNA-26a\/death-associated protein kinase 1 signaling induces synucleinopathy and dopaminergic neuron degeneration in parkinson\u2019s disease. Biol Psychiatry. 2019;85(9):769\u201381.","journal-title":"Biol Psychiatry"},{"issue":"5","key":"395_CR83","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/gim.2015.117","volume":"18","author":"C Van Cauwenberghe","year":"2016","unstructured":"Van Cauwenberghe C, Van Broeckhoven C, Sleegers K. The genetic landscape of Alzheimer disease: clinical implications and perspectives. Genet Med. 2016;18(5):421\u201330.","journal-title":"Genet Med"},{"issue":"R2","key":"395_CR84","doi-asserted-by":"publisher","first-page":"R137","DOI":"10.1093\/hmg\/ddp406","volume":"18","author":"L Bertram","year":"2009","unstructured":"Bertram L, Tanzi RE. Genome-wide association studies in Alzheimer\u2019s disease. Hum Mol Genet. 2009;18(R2):R137-145.","journal-title":"Hum Mol Genet"},{"issue":"2","key":"395_CR85","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.tig.2009.12.004","volume":"26","author":"K Sleegers","year":"2010","unstructured":"Sleegers K, Lambert JC, Bertram L, Cruts M, Amouyel P, Van Broeckhoven C. The pursuit of susceptibility genes for Alzheimer\u2019s disease: progress and prospects. Trends Genet. 2010;26(2):84\u201393.","journal-title":"Trends Genet"},{"issue":"2","key":"395_CR86","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s12264-016-0011-3","volume":"32","author":"L Shen","year":"2016","unstructured":"Shen L, Jia J. An overview of genome-wide association studies in Alzheimer\u2019s disease. Neurosci Bull. 2016;32(2):183\u201390.","journal-title":"Neurosci Bull"},{"issue":"4","key":"395_CR87","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/S1474-4422(19)30435-1","volume":"19","author":"SJ Andrews","year":"2020","unstructured":"Andrews SJ, Fulton-Howard B, Goate A. Interpretation of risk loci from genome-wide association studies of Alzheimer\u2019s disease. Lancet Neurol. 2020;19(4):326\u201335.","journal-title":"Lancet Neurol"},{"issue":"10113","key":"395_CR88","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1016\/S0140-6736(17)31363-6","volume":"390","author":"G Livingston","year":"2017","unstructured":"Livingston G, Sommerlad A, Orgeta V, Costafreda SG, Huntley J, Ames D, et al. Dementia prevention, intervention, and care. Lancet. 2017;390(10113):2673\u2013734.","journal-title":"Lancet"},{"issue":"1","key":"395_CR89","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/s41398-018-0221-8","volume":"8","author":"H Stocker","year":"2018","unstructured":"Stocker H, Mollers T, Perna L, Brenner H. The genetic risk of Alzheimer\u2019s disease beyond APOE epsilon4: systematic review of Alzheimer\u2019s genetic risk scores. Transl Psychiatry. 2018;8(1):166.","journal-title":"Transl Psychiatry"},{"issue":"9","key":"395_CR90","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41582-019-0228-7","volume":"15","author":"Y Yamazaki","year":"2019","unstructured":"Yamazaki Y, Zhao N, Caulfield TR, Liu CC, Bu G. Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies. Nat Rev Neurol. 2019;15(9):501\u201318.","journal-title":"Nat Rev Neurol"},{"key":"395_CR91","doi-asserted-by":"publisher","first-page":"115e111","DOI":"10.1016\/j.neurobiolaging.2021.02.019","volume":"104","author":"F Rajabli","year":"2021","unstructured":"Rajabli F, Feliciano-Astacio BE, Cukier HN, Wang L, Griswold AJ, Hamilton-Nelson KL, et al. Linkage of Alzheimer disease families with puerto rican ancestry identifies a chromosome 9 locus. Neurobiol Aging. 2021;104:115e111\u20137.","journal-title":"Neurobiol Aging"},{"issue":"11","key":"395_CR92","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1016\/j.neurobiolaging.2008.01.006","volume":"30","author":"RL Minster","year":"2009","unstructured":"Minster RL, DeKosky ST, Kamboh MI. No association of DAPK1 and ABCA2 SNPs on chromosome 9 with Alzheimer\u2019s disease. Neurobiol Aging. 2009;30(11):1890\u20131.","journal-title":"Neurobiol Aging"},{"issue":"4","key":"395_CR93","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.3233\/JAD-2010-100126","volume":"20","author":"G Laumet","year":"2010","unstructured":"Laumet G, Chouraki V, Grenier-Boley B, Legry V, Heath S, Zelenika D, et al. Systematic analysis of candidate genes for Alzheimer\u2019s disease in a French, genome-wide association study. J Alzheimers Dis. 2010;20(4):1181\u20138.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"395_CR94","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3233\/JAD-2012-120556","volume":"32","author":"A Tedde","year":"2012","unstructured":"Tedde A, Piaceri I, Bagnoli S, Lucenteforte E, Piacentini S, Sorbi S, et al. DAPK1 is associated with FTD and not with Alzheimer\u2019s disease. J Alzheimers Dis. 2012;32(1):13\u20137.","journal-title":"J Alzheimers Dis"},{"issue":"7","key":"395_CR95","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1007\/s10072-017-2959-9","volume":"38","author":"Y Hu","year":"2017","unstructured":"Hu Y, Cheng L, Zhang Y, Bai W, Zhou W, Wang T, et al. Rs4878104 contributes to Alzheimer\u2019s disease risk and regulates DAPK1 gene expression. Neurol Sci. 2017;38(7):1255\u201362.","journal-title":"Neurol Sci"},{"issue":"1","key":"395_CR96","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s10048-008-0150-4","volume":"10","author":"JS Kauwe","year":"2009","unstructured":"Kauwe JS, Wang J, Mayo K, Morris JC, Fagan AM, Holtzman DM, et al. Alzheimer\u2019s disease risk variants show association with cerebrospinal fluid amyloid beta. Neurogenetics. 2009;10(1):13\u20137.","journal-title":"Neurogenetics"},{"issue":"1","key":"395_CR97","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/j.1365-2990.2009.01035.x","volume":"36","author":"AH Hainsworth","year":"2010","unstructured":"Hainsworth AH, Allsopp RC, Jim A, Potter JF, Lowe J, Talbot CJ, et al. Death-associated protein kinase (DAPK1) in cerebral cortex of late-onset Alzheimer\u2019s disease patients and aged controls. Neuropathol Appl Neurobiol. 2010;36(1):17\u201324.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"395_CR98","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.pharmthera.2019.03.005","volume":"199","author":"A Eid","year":"2019","unstructured":"Eid A, Mhatre I, Richardson JR. Gene-environment interactions in Alzheimer\u2019s disease: a potential path to precision medicine. Pharmacol Ther. 2019;199:173\u201387.","journal-title":"Pharmacol Ther"},{"key":"395_CR99","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.jns.2018.01.003","volume":"387","author":"W Xiong","year":"2018","unstructured":"Xiong W, Wu Y, Xian W, Song L, Hu L, Pan S, et al. DAPK1-ERK signal mediates oxygen glucose deprivation reperfusion induced apoptosis in mouse N2a cells. J Neurol Sci. 2018;387:210\u20139.","journal-title":"J Neurol Sci"},{"issue":"11","key":"395_CR100","doi-asserted-by":"publisher","first-page":"4559","DOI":"10.1093\/cercor\/bhv096","volume":"25","author":"L Pei","year":"2015","unstructured":"Pei L, Wang S, Jin H, Bi L, Wei N, Yan H, et al. A novel mechanism of spine damages in stroke via DAPK1 and Tau. Cereb Cortex. 2015;25(11):4559\u201371.","journal-title":"Cereb Cortex"},{"issue":"19","key":"395_CR101","doi-asserted-by":"publisher","first-page":"6546","DOI":"10.1523\/JNEUROSCI.5119-13.2014","volume":"34","author":"L Pei","year":"2014","unstructured":"Pei L, Shang Y, Jin H, Wang S, Wei N, Yan H, et al. DAPK1-p53 interaction converges necrotic and apoptotic pathways of ischemic neuronal death. J Neurosci. 2014;34(19):6546\u201356.","journal-title":"J Neurosci"},{"issue":"1\u20132","key":"395_CR102","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/S1570-9639(02)00453-3","volume":"1600","author":"AM Schumacher","year":"2002","unstructured":"Schumacher AM, Velentza AV, Watterson DM, Wainwright MS. DAPK catalytic activity in the hippocampus increases during the recovery phase in an animal model of brain hypoxic-ischemic injury. Biochim Biophys Acta. 2002;1600(1\u20132):128\u201337.","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"395_CR103","doi-asserted-by":"publisher","first-page":"3001","DOI":"10.3892\/mmr.2017.6350","volume":"15","author":"TQ Huang","year":"2017","unstructured":"Huang TQ, Song JN, Zheng FW, Pang HG, Zhao YL, Gu H, et al. Protection of FK506 against neuronal apoptosis and axonal injury following experimental diffuse axonal injury. Mol Med Rep. 2017;15(5):3001\u201310.","journal-title":"Mol Med Rep"},{"key":"395_CR104","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2021.102072","volume":"203","author":"N Kim","year":"2021","unstructured":"Kim N, Wang B, Koikawa K, Nezu Y, Qiu C, Lee TH, et al. Inhibition of death-associated protein kinase 1 attenuates cis P-tau and neurodegeneration in traumatic brain injury. Prog Neurobiol. 2021;203: 102072.","journal-title":"Prog Neurobiol"},{"key":"395_CR105","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2022.892197","volume":"16","author":"Y Shi","year":"2022","unstructured":"Shi Y, Cui W, Wang Q, Zhou J, Wu X, Wang J, et al. MicroRNA-124\/death-associated protein Kinase 1 signaling regulates neuronal apoptosis in traumatic brain injury via phosphorylating NR2B. Front Cell Neurosci. 2022;16: 892197.","journal-title":"Front Cell Neurosci"},{"issue":"3","key":"395_CR106","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1002\/hipo.10184","volume":"14","author":"T Araki","year":"2004","unstructured":"Araki T, Shinoda S, Schindler CK, Quan-Lan J, Meller R, Taki W, et al. Expression, interaction, and proteolysis of death-associated protein kinase and p53 within vulnerable and resistant hippocampal subfields following seizures. Hippocampus. 2004;14(3):326\u201336.","journal-title":"Hippocampus"},{"key":"395_CR107","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2022.136638","volume":"782","author":"W Chen","year":"2022","unstructured":"Chen W, Hou C, Wang Y, Hong L, Wang F, Zhang J. Circular RNA circTLK1 regulates dopaminergic neuron injury during Parkinson\u2019s disease by targeting miR-26a-5p\/DAPK1. Neurosci Lett. 2022;782: 136638.","journal-title":"Neurosci Lett"},{"issue":"3","key":"395_CR108","doi-asserted-by":"publisher","first-page":"207","DOI":"10.5607\/en20014","volume":"29","author":"WH Shin","year":"2020","unstructured":"Shin WH, Chung KC. Death-associated protein kinase 1 phosphorylates alpha-synuclein at ser129 and exacerbates rotenone-induced toxic aggregation of alpha-synuclein in dopaminergic SH-SY5Y Cells. Exp Neurobiol. 2020;29(3):207\u201318.","journal-title":"Exp Neurobiol"},{"issue":"3","key":"395_CR109","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/mp.2017.85","volume":"23","author":"SX Li","year":"2018","unstructured":"Li SX, Han Y, Xu LZ, Yuan K, Zhang RX, Sun CY, et al. Uncoupling DAPK1 from NMDA receptor GluN2B subunit exerts rapid antidepressant-like effects. Mol Psychiatry. 2018;23(3):597\u2013608.","journal-title":"Mol Psychiatry"},{"issue":"8","key":"395_CR110","first-page":"1795","volume":"18","author":"XH Li","year":"2023","unstructured":"Li XH, Zhu HC, Cui XM, Wang W, Yang L, Wang LB, et al. Death-associated protein kinase 1 is associated with cognitive dysfunction in major depressive disorder. Neural Regen Res. 2023;18(8):1795\u2013801.","journal-title":"Neural Regen Res"},{"issue":"2","key":"395_CR111","doi-asserted-by":"publisher","first-page":"877","DOI":"10.3233\/JAD-220747","volume":"91","author":"LZ Xu","year":"2023","unstructured":"Xu LZ, Li BQ, Li FY, Li Y, Qin W, Zhao Y, et al. NMDA receptor GluN2B subunit is involved in excitotoxicity mediated by death-associated protein kinase 1 in Alzheimer\u2019s disease. J Alzheimers Dis. 2023;91(2):877\u201393.","journal-title":"J Alzheimers Dis"},{"issue":"42","key":"395_CR112","doi-asserted-by":"publisher","first-page":"10843","DOI":"10.1523\/JNEUROSCI.2258-16.2016","volume":"36","author":"S Shu","year":"2016","unstructured":"Shu S, Zhu H, Tang N, Chen W, Li X, Li H, et al. Selective degeneration of entorhinal-CA1 synapses in Alzheimer\u2019s disease via activation of DAPK1. J Neurosci. 2016;36(42):10843\u201352.","journal-title":"J Neurosci"},{"issue":"4","key":"395_CR113","doi-asserted-by":"publisher","first-page":"795","DOI":"10.3233\/JAD-130377","volume":"37","author":"DX Duan","year":"2013","unstructured":"Duan DX, Chai GS, Ni ZF, Hu Y, Luo Y, Cheng XS, et al. Phosphorylation of tau by death-associated protein kinase 1 antagonizes the kinase-induced cell apoptosis. J Alzheimers Dis. 2013;37(4):795\u2013808.","journal-title":"J Alzheimers Dis"},{"key":"395_CR114","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2020.590569","volume":"14","author":"ME Schmidt","year":"2020","unstructured":"Schmidt ME, Caron NS, Aly AE, Lemarie FL, Dal Cengio L, Ko Y, et al. DAPK1 promotes extrasynaptic GluN2B phosphorylation and striatal spine instability in the YAC128 mouse model of Huntington disease. Front Cell Neurosci. 2020;14: 590569.","journal-title":"Front Cell Neurosci"},{"issue":"5","key":"395_CR115","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s00401-019-02054-4","volume":"138","author":"D Mrdjen","year":"2019","unstructured":"Mrdjen D, Fox EJ, Bukhari SA, Montine KS, Bendall SC, Montine TJ. The basis of cellular and regional vulnerability in Alzheimer\u2019s disease. Acta Neuropathol. 2019;138(5):729\u201349.","journal-title":"Acta Neuropathol"},{"issue":"596","key":"395_CR116","doi-asserted-by":"publisher","first-page":"eaaz7615","DOI":"10.1126\/scitranslmed.aaz7615","volume":"13","author":"C Qiu","year":"2021","unstructured":"Qiu C, Albayram O, Kondo A, Wang B, Kim N, Arai K, et al. Cis P-tau underlies vascular contribution to cognitive impairment and dementia and can be effectively targeted by immunotherapy in mice. Sci Transl Med. 2021;13(596):eaaz7615.","journal-title":"Sci Transl Med."},{"key":"395_CR117","doi-asserted-by":"publisher","DOI":"10.1016\/j.mad.2022.111675","volume":"204","author":"MR Sahu","year":"2022","unstructured":"Sahu MR, Rani L, Subba R, Mondal AC. Cellular senescence in the aging brain: a promising target for neurodegenerative diseases. Mech Ageing Dev. 2022;204: 111675.","journal-title":"Mech Ageing Dev"},{"issue":"5","key":"395_CR118","doi-asserted-by":"publisher","first-page":"3368","DOI":"10.1007\/s12035-018-1312-5","volume":"56","author":"Y Guo","year":"2019","unstructured":"Guo Y, Li H, Ke X, Deng M, Wu Z, Cai Y, et al. Degradation of caytaxin causes learning and memory deficits via activation of DAPK1 in aging. Mol Neurobiol. 2019;56(5):3368\u201379.","journal-title":"Mol Neurobiol"},{"issue":"4","key":"395_CR119","doi-asserted-by":"publisher","first-page":"506","DOI":"10.14336\/AD.2016.1120","volume":"8","author":"A Szybinska","year":"2017","unstructured":"Szybinska A, Lesniak W. P53 dysfunction in neurodegenerative diseases - the cause or effect of pathological changes? Aging Dis. 2017;8(4):506\u201318.","journal-title":"Aging Dis"},{"issue":"8","key":"395_CR120","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1038\/sj.onc.1208256","volume":"24","author":"A Martoriati","year":"2005","unstructured":"Martoriati A, Doumont G, Alcalay M, Bellefroid E, Pelicci PG, Marine JC. dapk1, encoding an activator of a p19ARF-p53-mediated apoptotic checkpoint, is a transcription target of p53. Oncogene. 2005;24(8):1461\u20136.","journal-title":"Oncogene"},{"issue":"2","key":"395_CR121","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1006\/bbrc.1997.6301","volume":"232","author":"Y Kitamura","year":"1997","unstructured":"Kitamura Y, Shimohama S, Kamoshima W, Matsuoka Y, Nomura Y, Taniguchi T. Changes of p53 in the brains of patients with Alzheimer\u2019s disease. Biochem Biophys Res Commun. 1997;232(2):418\u201321.","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"395_CR122","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1096\/fj.04-2637fje","volume":"19","author":"Y Ohyagi","year":"2005","unstructured":"Ohyagi Y, Asahara H, Chui DH, Tsuruta Y, Sakae N, Miyoshi K, et al. Intracellular Abeta42 activates p53 promoter: a pathway to neurodegeneration in Alzheimer\u2019s disease. FASEB J. 2005;19(2):255\u20137.","journal-title":"FASEB J"},{"key":"395_CR123","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.neuroscience.2023.06.024","volume":"526","author":"Y Zhou","year":"2023","unstructured":"Zhou Y, Zhang X, Yang H, Chu B, Zhen M, Zhang J, et al. Mechanism of cAMP response element-binding protein 1\/death-associated protein kinase 1 axis-mediated hippocampal neuron apoptosis in rat brain injury after cardiopulmonary resuscitation. Neuroscience. 2023;526:175\u201384.","journal-title":"Neuroscience"},{"issue":"9","key":"395_CR124","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1038\/mp.2016.111","volume":"21","author":"N Bartolotti","year":"2016","unstructured":"Bartolotti N, Bennett DA, Lazarov O. Reduced pCREB in Alzheimer\u2019s disease prefrontal cortex is reflected in peripheral blood mononuclear cells. Mol Psychiatry. 2016;21(9):1158\u201366.","journal-title":"Mol Psychiatry"},{"key":"395_CR125","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.103970","volume":"78","author":"Q Zhou","year":"2022","unstructured":"Zhou Q, Li S, Li M, Ke D, Wang Q, Yang Y, et al. Human tau accumulation promotes glycogen synthase kinase-3beta acetylation and thus upregulates the kinase: a vicious cycle in Alzheimer neurodegeneration. EBioMedicine. 2022;78: 103970.","journal-title":"EBioMedicine"},{"issue":"Pt 11","key":"395_CR126","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1242\/jcs.147553","volume":"127","author":"K Shah","year":"2014","unstructured":"Shah K, Lahiri DK. Cdk5 activity in the brain - multiple paths of regulation. J Cell Sci. 2014;127(Pt 11):2391\u2013400.","journal-title":"J Cell Sci"},{"issue":"3","key":"395_CR127","doi-asserted-by":"publisher","first-page":"e96","DOI":"10.1016\/S2666-7568(20)30015-5","volume":"1","author":"P Li","year":"2020","unstructured":"Li P, Gao L, Gaba A, Yu L, Cui L, Fan W, et al. Circadian disturbances in Alzheimer\u2019s disease progression: a prospective observational cohort study of community-based older adults. Lancet Healthy Longev. 2020;1(3):e96\u2013105.","journal-title":"Lancet Healthy Longev"},{"key":"395_CR128","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/B978-0-12-819975-6.00021-2","volume":"179","author":"P Pevet","year":"2021","unstructured":"Pevet P, Challet E, Felder-Schmittbuhl MP. Melatonin and the circadian system: keys for health with a focus on sleep. Handb Clin Neurol. 2021;179:331\u201343.","journal-title":"Handb Clin Neurol"},{"issue":"2","key":"395_CR129","doi-asserted-by":"publisher","DOI":"10.1111\/jpi.12665","volume":"69","author":"D Chen","year":"2020","unstructured":"Chen D, Mei Y, Kim N, Lan G, Gan CL, Fan F, et al. Melatonin directly binds and inhibits death-associated protein kinase 1 function in Alzheimer\u2019s disease. J Pineal Res. 2020;69(2): e12665.","journal-title":"J Pineal Res"},{"key":"395_CR130","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110887","volume":"132","author":"Y Li","year":"2020","unstructured":"Li Y, Zhang J, Wan J, Liu A, Sun J. Melatonin regulates Abeta production\/clearance balance and Abeta neurotoxicity: a potential therapeutic molecule for Alzheimer\u2019s disease. Biomed Pharmacother. 2020;132: 110887.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"395_CR131","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s40035-022-00302-4","volume":"11","author":"D Chen","year":"2022","unstructured":"Chen D, Lan G, Li R, Mei Y, Shui X, Gu X, et al. Melatonin ameliorates tau-related pathology via the miR-504-3p and CDK5 axis in Alzheimer\u2019s disease. Transl Neurodegener. 2022;11(1):27.","journal-title":"Transl Neurodegener"},{"issue":"2","key":"395_CR132","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1007\/s10495-013-0936-1","volume":"19","author":"PJ Gallagher","year":"2014","unstructured":"Gallagher PJ, Blue EK. Post-translational regulation of the cellular levels of DAPK. Apoptosis. 2014;19(2):306\u201315.","journal-title":"Apoptosis"},{"key":"395_CR133","doi-asserted-by":"publisher","first-page":"254","DOI":"10.3389\/fnins.2017.00254","volume":"11","author":"RE Lackie","year":"2017","unstructured":"Lackie RE, Maciejewski A, Ostapchenko VG, Marques-Lopes J, Choy WY, Duennwald ML, et al. The Hsp70\/Hsp90 chaperone machinery in neurodegenerative diseases. Front Neurosci. 2017;11:254.","journal-title":"Front Neurosci"},{"issue":"2","key":"395_CR134","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2020.11.016","volume":"433","author":"H Wang","year":"2021","unstructured":"Wang H, Lallemang M, Hermann B, Wallin C, Loch R, Blanc A, et al. ATP impedes the inhibitory effect of Hsp90 on Abeta(40) fibrillation. J Mol Biol. 2021;433(2): 166717.","journal-title":"J Mol Biol"},{"issue":"2","key":"395_CR135","doi-asserted-by":"publisher","first-page":"693","DOI":"10.7150\/ijbs.66760","volume":"18","author":"T Zhang","year":"2022","unstructured":"Zhang T, Xia Y, Hu L, Chen D, Gan CL, Wang L, et al. Death-associated protein kinase 1 mediates Abeta42 aggregation-induced neuronal apoptosis and tau dysregulation in Alzheimer\u2019s disease. Int J Biol Sci. 2022;18(2):693\u2013706.","journal-title":"Int J Biol Sci"},{"key":"395_CR136","doi-asserted-by":"publisher","first-page":"153331752110205","DOI":"10.1177\/15333175211020572","volume":"36","author":"Y Wang","year":"2021","unstructured":"Wang Y, Shi M, Hong Z, Kang J, Pan H, Yan C. MiR-130a-3p has protective effects in Alzheimer\u2019s disease via targeting DAPK1. Am J Alzheimers Dis Other Demen. 2021;36:15333175211020572.","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"395_CR137","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.649982","volume":"15","author":"Y Shi","year":"2021","unstructured":"Shi Y, Tian T, Cai EL, Yang C, Yang X. miR-214 alleviates ischemic stroke-induced neuronal death by targeting DAPK1 in mice. Front Neurosci. 2021;15: 649982.","journal-title":"Front Neurosci"},{"issue":"3","key":"395_CR138","doi-asserted-by":"publisher","first-page":"883","DOI":"10.3233\/JAD-191091","volume":"74","author":"H Almansoub","year":"2020","unstructured":"Almansoub H, Tang H, Wu Y, Wang DQ, Mahaman YAR, Salissou MTM, et al. Oxytocin alleviates MPTP-induced neurotoxicity in mice by targeting microRNA-26a\/death-associated protein kinase 1 pathway. J Alzheimers Dis. 2020;74(3):883\u2013901.","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"395_CR139","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.gpb.2019.09.004","volume":"17","author":"N Ludwig","year":"2019","unstructured":"Ludwig N, Fehlmann T, Kern F, Gogol M, Maetzler W, Deutscher S, et al. Machine learning to detect Alzheimer\u2019s disease from circulating non-coding RNAs. Genomics Proteomics Bioinformatics. 2019;17(4):430\u201340.","journal-title":"Genomics Proteomics Bioinformatics"},{"issue":"3","key":"395_CR140","doi-asserted-by":"publisher","first-page":"241","DOI":"10.2174\/1567202617666200414142637","volume":"17","author":"Y Liu","year":"2020","unstructured":"Liu Y, Wang L, Xie F, Wang X, Hou Y, Wang X, et al. Overexpression of miR-26a-5p suppresses tau phosphorylation and Abeta accumulation in the Alzheimer\u2019s disease mice by targeting DYRK1A. Curr Neurovasc Res. 2020;17(3):241\u20138.","journal-title":"Curr Neurovasc Res"},{"key":"395_CR141","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.conb.2021.03.003","volume":"69","author":"S Wegmann","year":"2021","unstructured":"Wegmann S, Biernat J, Mandelkow E. A current view on Tau protein phosphorylation in Alzheimer\u2019s disease. Curr Opin Neurobiol. 2021;69:131\u20138.","journal-title":"Curr Opin Neurobiol"},{"issue":"52","key":"395_CR142","doi-asserted-by":"publisher","first-page":"18213","DOI":"10.1074\/jbc.RA120.015882","volume":"295","author":"F Drepper","year":"2020","unstructured":"Drepper F, Biernat J, Kaniyappan S, Meyer HE, Mandelkow EM, Warscheid B, et al. A combinatorial native MS and LC-MS\/MS approach reveals high intrinsic phosphorylation of human Tau but minimal levels of other key modifications. J Biol Chem. 2020;295(52):18213\u201325.","journal-title":"J Biol Chem"},{"issue":"11","key":"395_CR143","doi-asserted-by":"publisher","first-page":"2924","DOI":"10.1016\/j.chempr.2020.09.012","volume":"6","author":"G Nam","year":"2020","unstructured":"Nam G, Lin Y, Lim MH, Lee Y-H. Key physicochemical and biological factors of the phase behavior of Tau. Chem. 2020;6(11):2924\u201363.","journal-title":"Chem"},{"issue":"6","key":"395_CR144","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1016\/j.cell.2020.10.029","volume":"183","author":"H Wesseling","year":"2020","unstructured":"Wesseling H, Mair W, Kumar M, Schlaffner CN, Tang S, Beerepoot P, et al. Tau PTM profiles identify patient heterogeneity and stages of Alzheimer\u2019s disease. Cell. 2020;183(6):1699\u2013713.","journal-title":"Cell"},{"issue":"9","key":"395_CR145","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1038\/cdd.2011.2","volume":"18","author":"PR Wu","year":"2011","unstructured":"Wu PR, Tsai PI, Chen GC, Chou HJ, Huang YP, Chen YH, et al. DAPK activates MARK1\/2 to regulate microtubule assembly, neuronal differentiation, and Tau toxicity. Cell Death Differ. 2011;18(9):1507\u201320.","journal-title":"Cell Death Differ"},{"issue":"3","key":"395_CR146","doi-asserted-by":"publisher","first-page":"699","DOI":"10.3233\/JAD-2012-121357","volume":"33","author":"GJ Gu","year":"2013","unstructured":"Gu GJ, Wu D, Lund H, Sunnemark D, Kvist AJ, Milner R, et al. Elevated MARK2-dependent phosphorylation of Tau in Alzheimer\u2019s disease. J Alzheimers Dis. 2013;33(3):699\u2013713.","journal-title":"J Alzheimers Dis"},{"issue":"6738","key":"395_CR147","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1038\/21650","volume":"399","author":"PJ Lu","year":"1999","unstructured":"Lu PJ, Wulf G, Zhou XZ, Davies P, Lu KP. The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein. Nature. 1999;399(6738):784\u20138.","journal-title":"Nature"},{"key":"395_CR148","doi-asserted-by":"publisher","first-page":"355","DOI":"10.3389\/fcell.2020.00355","volume":"8","author":"L Wang","year":"2020","unstructured":"Wang L, Zhou Y, Chen D, Lee TH. Peptidyl-Prolyl cis\/trans Isomerase Pin1 and Alzheimer\u2019s Disease. Front Cell Dev Biol. 2020;8:355.","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"395_CR149","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3233\/JAD-2010-091279","volume":"21","author":"HH Wang","year":"2010","unstructured":"Wang HH, Li HL, Liu R, Zhang Y, Liao K, Wang Q, et al. Tau overexpression inhibits cell apoptosis with the mechanisms involving multiple viability-related factors. J Alzheimers Dis. 2010;21(1):167\u201379.","journal-title":"J Alzheimers Dis"},{"issue":"10","key":"395_CR150","doi-asserted-by":"publisher","first-page":"3089","DOI":"10.1161\/STROKEAHA.114.006348","volume":"45","author":"X Wang","year":"2014","unstructured":"Wang X, Pei L, Yan H, Wang Z, Wei N, Wang S, et al. Intervention of death-associated protein kinase 1\u2013p53 interaction exerts the therapeutic effects against stroke. Stroke. 2014;45(10):3089\u201391.","journal-title":"Stroke"},{"issue":"9","key":"395_CR151","doi-asserted-by":"publisher","first-page":"e1347","DOI":"10.1212\/WNL.0000000000011524","volume":"96","author":"WJ Jagust","year":"2021","unstructured":"Jagust WJ, Landau SM. Alzheimer\u2019s disease neuroimaging I. temporal dynamics of beta-amyloid accumulation in aging and Alzheimer disease. Neurology. 2021;96(9):e1347\u201357.","journal-title":"Neurology"},{"issue":"7","key":"395_CR152","doi-asserted-by":"publisher","first-page":"3617","DOI":"10.1007\/s12035-023-03277-z","volume":"60","author":"PP Guan","year":"2023","unstructured":"Guan PP, Wang P. The involvement of post-translational modifications in regulating the development and progression of alzheimer\u2019s disease. Mol Neurobiol. 2023;60(7):3617\u201332.","journal-title":"Mol Neurobiol"},{"issue":"3","key":"395_CR153","doi-asserted-by":"publisher","first-page":"937","DOI":"10.3233\/JAD-210337","volume":"84","author":"XJ Song","year":"2021","unstructured":"Song XJ, Zhou HY, Sun YY, Huang HC. Phosphorylation and glycosylation of amyloid-beta protein precursor: the relationship to trafficking and cleavage in Alzheimer\u2019s disease. J Alzheimers Dis. 2021;84(3):937\u201357.","journal-title":"J Alzheimers Dis"},{"issue":"7083","key":"395_CR154","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/nature04543","volume":"440","author":"L Pastorino","year":"2006","unstructured":"Pastorino L, Sun A, Lu PJ, Zhou XZ, Balastik M, Finn G, et al. The prolyl isomerase Pin1 regulates amyloid precursor protein processing and amyloid-beta production. Nature. 2006;440(7083):528\u201334.","journal-title":"Nature"},{"key":"395_CR155","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ebiom.2016.03.035","volume":"6","author":"U Sengupta","year":"2016","unstructured":"Sengupta U, Nilson AN, Kayed R. The role of amyloid-beta oligomers in toxicity, propagation, and immunotherapy. EBioMedicine. 2016;6:42\u20139.","journal-title":"EBioMedicine"},{"issue":"2","key":"395_CR156","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/j.1582-4934.2009.00990.x","volume":"15","author":"YT Cheung","year":"2011","unstructured":"Cheung YT, Zhang NQ, Hung CH, Lai CS, Yu MS, So KF, et al. Temporal relationship of autophagy and apoptosis in neurons challenged by low molecular weight beta-amyloid peptide. J Cell Mol Med. 2011;15(2):244\u201357.","journal-title":"J Cell Mol Med"},{"issue":"1","key":"395_CR157","doi-asserted-by":"publisher","first-page":"9930","DOI":"10.1038\/s41598-018-27842-y","volume":"8","author":"L Song","year":"2018","unstructured":"Song L, Pei L, Hu L, Pan S, Xiong W, Liu M, et al. Death-associated protein kinase 1 mediates interleukin-1beta production through regulating inlfammasome activation in Bv2 microglial cells and mice. Sci Rep. 2018;8(1):9930.","journal-title":"Sci Rep"},{"issue":"2","key":"395_CR158","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1152\/physrev.00011.2017","volume":"98","author":"M Fricker","year":"2018","unstructured":"Fricker M, Tolkovsky AM, Borutaite V, Coleman M, Brown GC. Neuronal cell death. Physiol Rev. 2018;98(2):813\u201380.","journal-title":"Physiol Rev"},{"issue":"7","key":"395_CR159","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1038\/s41418-021-00814-y","volume":"28","author":"D Moujalled","year":"2021","unstructured":"Moujalled D, Strasser A, Liddell JR. Molecular mechanisms of cell death in neurological diseases. Cell Death Differ. 2021;28(7):2029\u201344.","journal-title":"Cell Death Differ"},{"key":"395_CR160","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.703876","volume":"13","author":"JL Martinez","year":"2021","unstructured":"Martinez JL, Zammit MD, West NR, Christian BT, Bhattacharyya A. Basal forebrain cholinergic neurons: linking down syndrome and Alzheimer\u2019s disease. Front Aging Neurosci. 2021;13: 703876.","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"395_CR161","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2174\/1570159X13666150716165726","volume":"14","author":"TH Ferreira-Vieira","year":"2016","unstructured":"Ferreira-Vieira TH, Guimaraes IM, Silva FR, Ribeiro FM. Alzheimer\u2019s disease: targeting the cholinergic system. Curr Neuropharmacol. 2016;14(1):101\u201315.","journal-title":"Curr Neuropharmacol"},{"issue":"2","key":"395_CR162","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.bbr.2010.11.058","volume":"221","author":"R Schliebs","year":"2011","unstructured":"Schliebs R, Arendt T. The cholinergic system in aging and neuronal degeneration. Behav Brain Res. 2011;221(2):555\u201363.","journal-title":"Behav Brain Res"},{"key":"395_CR163","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1146\/annurev.neuro.23.1.73","volume":"23","author":"D Nijhawan","year":"2000","unstructured":"Nijhawan D, Honarpour N, Wang X. Apoptosis in neural development and disease. Annu Rev Neurosci. 2000;23:73\u201387.","journal-title":"Annu Rev Neurosci"},{"issue":"5","key":"395_CR164","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1152\/jn.00055.2021","volume":"125","author":"DJ Goodell","year":"2021","unstructured":"Goodell DJ, Tullis JE, Bayer KU. Young DAPK1 knockout mice have altered presynaptic function. J Neurophysiol. 2021;125(5):1973\u201381.","journal-title":"J Neurophysiol"},{"issue":"5","key":"395_CR165","first-page":"869","volume":"17","author":"K Yukawa","year":"2006","unstructured":"Yukawa K, Tanaka T, Bai T, Li L, Tsubota Y, Owada-Makabe K, et al. Deletion of the kinase domain from death-associated protein kinase enhances spatial memory in mice. Int J Mol Med. 2006;17(5):869\u201373.","journal-title":"Int J Mol Med"},{"issue":"3","key":"395_CR166","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1083\/jcb.200109094","volume":"157","author":"B Inbal","year":"2002","unstructured":"Inbal B, Bialik S, Sabanay I, Shani G, Kimchi A. DAP kinase and DRP-1 mediate membrane blebbing and the formation of autophagic vesicles during programmed cell death. J Cell Biol. 2002;157(3):455\u201368.","journal-title":"J Cell Biol"},{"issue":"6","key":"395_CR167","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/sj.cdd.4401386","volume":"11","author":"S Bialik","year":"2004","unstructured":"Bialik S, Bresnick AR, Kimchi A. DAP-kinase-mediated morphological changes are localization dependent and involve myosin-II phosphorylation. Cell Death Differ. 2004;11(6):631\u201344.","journal-title":"Cell Death Differ"},{"issue":"2","key":"395_CR168","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/cdd.2016.114","volume":"24","author":"MH You","year":"2017","unstructured":"You MH, Kim BM, Chen CH, Begley MJ, Cantley LC, Lee TH. Death-associated protein kinase 1 phosphorylates NDRG2 and induces neuronal cell death. Cell Death Differ. 2017;24(2):238\u201350.","journal-title":"Cell Death Differ"},{"issue":"2","key":"395_CR169","doi-asserted-by":"publisher","first-page":"259","DOI":"10.3233\/JAD-2011-110405","volume":"27","author":"MM Mielke","year":"2011","unstructured":"Mielke MM, Haughey NJ, Bandaru VV, Weinberg DD, Darby E, Zaidi N, et al. Plasma sphingomyelins are associated with cognitive progression in Alzheimer\u2019s disease. J Alzheimers Dis. 2011;27(2):259\u201369.","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"395_CR170","doi-asserted-by":"publisher","first-page":"537","DOI":"10.3233\/JAD-2011-111202","volume":"29","author":"V Filippov","year":"2012","unstructured":"Filippov V, Song MA, Zhang K, Vinters HV, Tung S, Kirsch WM, et al. Increased ceramide in brains with Alzheimer\u2019s and other neurodegenerative diseases. J Alzheimers Dis. 2012;29(3):537\u201347.","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"395_CR171","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1074\/jbc.M104677200","volume":"277","author":"D Pelled","year":"2002","unstructured":"Pelled D, Raveh T, Riebeling C, Fridkin M, Berissi H, Futerman AH, et al. Death-associated protein (DAP) kinase plays a central role in ceramide-induced apoptosis in cultured hippocampal neurons. J Biol Chem. 2002;277(3):1957\u201361.","journal-title":"J Biol Chem"},{"issue":"18","key":"395_CR172","doi-asserted-by":"publisher","first-page":"13827","DOI":"10.1074\/jbc.M109.085076","volume":"285","author":"RC Widau","year":"2010","unstructured":"Widau RC, Jin Y, Dixon SA, Wadzinski BE, Gallagher PJ. Protein phosphatase 2A (PP2A) holoenzymes regulate death-associated protein kinase (DAPK) in ceramide-induced anoikis. J Biol Chem. 2010;285(18):13827\u201338.","journal-title":"J Biol Chem"},{"issue":"12","key":"395_CR173","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/nm.3736","volume":"20","author":"MK Wetzel-Smith","year":"2014","unstructured":"Wetzel-Smith MK, Hunkapiller J, Bhangale TR, Srinivasan K, Maloney JA, Atwal JK, et al. A rare mutation in UNC5C predisposes to late-onset Alzheimer\u2019s disease and increases neuronal cell death. Nat Med. 2014;20(12):1452\u20137.","journal-title":"Nat Med"},{"issue":"23","key":"395_CR174","doi-asserted-by":"publisher","first-page":"12282","DOI":"10.1074\/jbc.M115.698092","volume":"291","author":"Y Hashimoto","year":"2016","unstructured":"Hashimoto Y, Toyama Y, Kusakari S, Nawa M, Matsuoka M. An Alzheimer disease-linked rare mutation potentiates netrin receptor uncoordinated-5C-induced signaling that merges with amyloid beta precursor protein signaling. J Biol Chem. 2016;291(23):12282\u201393.","journal-title":"J Biol Chem"},{"issue":"6","key":"395_CR175","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1038\/sj.emboj.7600584","volume":"24","author":"F Llambi","year":"2005","unstructured":"Llambi F, Lourenco FC, Gozuacik D, Guix C, Pays L, Del Rio G, et al. The dependence receptor UNC5H2 mediates apoptosis through DAP-kinase. EMBO J. 2005;24(6):1192\u2013201.","journal-title":"EMBO J"},{"issue":"6","key":"395_CR176","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.molcel.2010.11.021","volume":"40","author":"C Guenebeaud","year":"2010","unstructured":"Guenebeaud C, Goldschneider D, Castets M, Guix C, Chazot G, Delloye-Bourgeois C, et al. The dependence receptor UNC5H2\/B triggers apoptosis via PP2A-mediated dephosphorylation of DAP kinase. Mol Cell. 2010;40(6):863\u201376.","journal-title":"Mol Cell"},{"issue":"2","key":"395_CR177","doi-asserted-by":"publisher","first-page":"fcac083","DOI":"10.1093\/braincomms\/fcac083","volume":"4","author":"R Martinez-Serra","year":"2022","unstructured":"Martinez-Serra R, Alonso-Nanclares L, Cho K, Giese KP. Emerging insights into synapse dysregulation in Alzheimer\u2019s disease. Brain Commun. 2022;4(2):fcac083.","journal-title":"Brain Commun."},{"key":"395_CR178","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-023-03674-4","author":"Y Tian","year":"2023","unstructured":"Tian Y, Zheng X, Li R, Hu L, Shui X, Wang L, et al. Quantitative proteomic and phosphoproteomic analyses reveal a role of death-associated protein kinase 1 in regulating hippocampal synapse. Mol Neurobiol. 2023. https:\/\/doi.org\/10.1007\/s12035-023-03674-4.","journal-title":"Mol Neurobiol"},{"issue":"6","key":"395_CR179","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/j.neuron.2008.08.020","volume":"59","author":"MJ Higley","year":"2008","unstructured":"Higley MJ, Sabatini BL. Calcium signaling in dendrites and spines: practical and functional considerations. Neuron. 2008;59(6):902\u201313.","journal-title":"Neuron"},{"issue":"6","key":"395_CR180","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/nrn2153","volume":"8","author":"CG Lau","year":"2007","unstructured":"Lau CG, Zukin RS. NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders. Nat Rev Neurosci. 2007;8(6):413\u201326.","journal-title":"Nat Rev Neurosci"},{"issue":"11","key":"395_CR181","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1016\/j.celrep.2017.05.068","volume":"19","author":"DJ Goodell","year":"2017","unstructured":"Goodell DJ, Zaegel V, Coultrap SJ, Hell JW, Bayer KU. DAPK1 mediates LTD by making CaMKII\/GluN2B binding LTP specific. Cell Rep. 2017;19(11):2231\u201343.","journal-title":"Cell Rep"},{"key":"395_CR182","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2020.113303","volume":"329","author":"S Wang","year":"2020","unstructured":"Wang S, Chen K, Yu J, Wang X, Li Q, Lv F, et al. Presynaptic Caytaxin prevents apoptosis via deactivating DAPK1 in the acute phase of cerebral ischemic stroke. Exp Neurol. 2020;329: 113303.","journal-title":"Exp Neurol"},{"key":"395_CR183","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1146\/annurev-biophys-060414-034057","volume":"44","author":"J Rizo","year":"2015","unstructured":"Rizo J, Xu J. The synaptic vesicle release machinery. Annu Rev Biophys. 2015;44:339\u201367.","journal-title":"Annu Rev Biophys"},{"issue":"5067","key":"395_CR184","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1126\/science.1321498","volume":"257","author":"MK Bennett","year":"1992","unstructured":"Bennett MK, Calakos N, Scheller RH. Syntaxin: a synaptic protein implicated in docking of synaptic vesicles at presynaptic active zones. Science. 1992;257(5067):255\u20139.","journal-title":"Science"},{"issue":"7","key":"395_CR185","doi-asserted-by":"publisher","first-page":"6542","DOI":"10.3390\/ijms24076542","volume":"24","author":"R Li","year":"2023","unstructured":"Li R, Zhi S, Lan G, Chen X, Zheng X, Hu L, et al. Ablation of death-associated protein kinase 1 changes the transcriptomic profile and alters neural-related pathways in the brain. Int J Mol Sci. 2023;24(7):6542.","journal-title":"Int J Mol Sci"},{"key":"395_CR186","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/B978-0-12-804766-8.00013-3","volume":"167","author":"JA Soria Lopez","year":"2019","unstructured":"Soria Lopez JA, Gonzalez HM, Leger GC. Alzheimer\u2019s disease. Handb Clin Neurol. 2019;167:231\u201355.","journal-title":"Handb Clin Neurol"},{"issue":"2","key":"395_CR187","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1083\/jcb.201709069","volume":"217","author":"DV Hansen","year":"2018","unstructured":"Hansen DV, Hanson JE, Sheng M. Microglia in Alzheimer\u2019s disease. J Cell Biol. 2018;217(2):459\u201372.","journal-title":"J Cell Biol"},{"issue":"3","key":"395_CR188","doi-asserted-by":"publisher","first-page":"540","DOI":"10.3390\/cells10030540","volume":"10","author":"P Preman","year":"2021","unstructured":"Preman P, Alfonso-Triguero M, Alberdi E, Verkhratsky A, Arranz AM. Astrocytes in Alzheimer\u2019s disease: pathological significance and molecular pathways. Cells. 2021;10(3):540.","journal-title":"Cells"},{"issue":"4","key":"395_CR189","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1007\/s11011-022-00953-2","volume":"37","author":"RAL De Sousa","year":"2022","unstructured":"De Sousa RAL. Reactive gliosis in Alzheimer\u2019s disease: a crucial role for cognitive impairment and memory loss. Metab Brain Dis. 2022;37(4):851\u20137.","journal-title":"Metab Brain Dis"},{"issue":"23","key":"395_CR190","doi-asserted-by":"publisher","first-page":"16792","DOI":"10.1074\/jbc.M611559200","volume":"282","author":"Y Lin","year":"2007","unstructured":"Lin Y, Stevens C, Hupp T. Identification of a dominant negative functional domain on DAPK-1 that degrades DAPK-1 protein and stimulates TNFR-1-mediated apoptosis. J Biol Chem. 2007;282(23):16792\u2013802.","journal-title":"J Biol Chem"},{"issue":"2","key":"395_CR191","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1002\/jnr.24419","volume":"98","author":"E Gabande-Rodriguez","year":"2020","unstructured":"Gabande-Rodriguez E, Keane L, Capasso M. Microglial phagocytosis in aging and Alzheimer\u2019s disease. J Neurosci Res. 2020;98(2):284\u201398.","journal-title":"J Neurosci Res"},{"issue":"3","key":"395_CR192","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.cell.2019.05.056","volume":"178","author":"BL Heckmann","year":"2019","unstructured":"Heckmann BL, Teubner BJW, Tummers B, Boada-Romero E, Harris L, Yang M, et al. LC3-associated endocytosis facilitates beta-amyloid clearance and mitigates neurodegeneration in murine Alzheimer\u2019s disease. Cell. 2019;178(3):536\u201351.","journal-title":"Cell"},{"issue":"27","key":"395_CR193","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2023418118","volume":"118","author":"Y Xu","year":"2021","unstructured":"Xu Y, Propson NE, Du S, Xiong W, Zheng H. Autophagy deficiency modulates microglial lipid homeostasis and aggravates tau pathology and spreading. Proc Natl Acad Sci U S A. 2021;118(27): e2023418118.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"395_CR194","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.4161\/auto.29647","volume":"10","author":"MH Cho","year":"2014","unstructured":"Cho MH, Cho K, Kang HJ, Jeon EY, Kim HS, Kwon HJ, et al. Autophagy in microglia degrades extracellular beta-amyloid fibrils and regulates the NLRP3 inflammasome. Autophagy. 2014;10(10):1761\u201375.","journal-title":"Autophagy"},{"issue":"5","key":"395_CR195","doi-asserted-by":"publisher","first-page":"720","DOI":"10.4161\/auto.5.5.8625","volume":"5","author":"E Zalckvar","year":"2009","unstructured":"Zalckvar E, Berissi H, Eisenstein M, Kimchi A. Phosphorylation of Beclin 1 by DAP-kinase promotes autophagy by weakening its interactions with Bcl-2 and Bcl-XL. Autophagy. 2009;5(5):720\u20132.","journal-title":"Autophagy"},{"issue":"3","key":"395_CR196","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/embor.2008.246","volume":"10","author":"E Zalckvar","year":"2009","unstructured":"Zalckvar E, Berissi H, Mizrachy L, Idelchuk Y, Koren I, Eisenstein M, et al. DAP-kinase-mediated phosphorylation on the BH3 domain of beclin 1 promotes dissociation of beclin 1 from Bcl-XL and induction of autophagy. EMBO Rep. 2009;10(3):285\u201392.","journal-title":"EMBO Rep"},{"issue":"15","key":"395_CR197","doi-asserted-by":"publisher","first-page":"9999","DOI":"10.1074\/jbc.M706040200","volume":"283","author":"B Harrison","year":"2008","unstructured":"Harrison B, Kraus M, Burch L, Stevens C, Craig A, Gordon-Weeks P, et al. DAPK-1 binding to a linear peptide motif in MAP1B stimulates autophagy and membrane blebbing. J Biol Chem. 2008;283(15):9999\u201310014.","journal-title":"J Biol Chem"},{"issue":"4","key":"395_CR198","doi-asserted-by":"publisher","first-page":"531","DOI":"10.4161\/auto.5940","volume":"4","author":"C Stevens","year":"2008","unstructured":"Stevens C, Hupp TR. Novel insights into DAPK autophagic signalling using peptide aptamer combinatorial protein-interaction screens. Autophagy. 2008;4(4):531\u20133.","journal-title":"Autophagy"},{"issue":"6","key":"395_CR199","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.chom.2016.10.012","volume":"20","author":"V Oikonomou","year":"2016","unstructured":"Oikonomou V, Moretti S, Renga G, Galosi C, Borghi M, Pariano M, et al. Noncanonical fungal autophagy inhibits inflammation in response to IFN-gamma via DAPK1. Cell Host Microbe. 2016;20(6):744\u201357.","journal-title":"Cell Host Microbe"},{"issue":"1","key":"395_CR200","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s12964-023-01173-6","volume":"21","author":"XX Chen","year":"2023","unstructured":"Chen XX, Tao T, Liu XZ, Wu W, Wang JW, Yue TT, et al. P38-DAPK1 axis regulated LC3-associated phagocytosis (LAP) of microglia in an in vitro subarachnoid hemorrhage model. Cell Commun Signal. 2023;21(1):175.","journal-title":"Cell Commun Signal"},{"issue":"2","key":"395_CR201","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1021\/acs.jmedchem.2c01606","volume":"66","author":"L Zhang","year":"2023","unstructured":"Zhang L, Luo B, Lu Y, Chen Y. Targeting death-associated protein kinases for treatment of human diseases: recent advances and future directions. J Med Chem. 2023;66(2):1112\u201336.","journal-title":"J Med Chem"},{"issue":"20","key":"395_CR202","doi-asserted-by":"publisher","first-page":"3465","DOI":"10.1016\/S0960-894X(03)00733-9","volume":"13","author":"AV Velentza","year":"2003","unstructured":"Velentza AV, Wainwright MS, Zasadzki M, Mirzoeva S, Schumacher AM, Haiech J, et al. An aminopyridazine-based inhibitor of a pro-apoptotic protein kinase attenuates hypoxia-ischemia induced acute brain injury. Bioorg Med Chem Lett. 2003;13(20):3465\u201370.","journal-title":"Bioorg Med Chem Lett"},{"issue":"7","key":"395_CR203","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.1016\/j.bmc.2010.02.018","volume":"18","author":"M Okamoto","year":"2010","unstructured":"Okamoto M, Takayama K, Shimizu T, Muroya A, Furuya T. Structure-activity relationship of novel DAPK inhibitors identified by structure-based virtual screening. Bioorg Med Chem. 2010;18(7):2728\u201334.","journal-title":"Bioorg Med Chem"},{"issue":"22","key":"395_CR204","doi-asserted-by":"publisher","first-page":"7323","DOI":"10.1021\/jm901191q","volume":"52","author":"M Okamoto","year":"2009","unstructured":"Okamoto M, Takayama K, Shimizu T, Ishida K, Takahashi O, Furuya T. Identification of death-associated protein kinases inhibitors using structure-based virtual screening. J Med Chem. 2009;52(22):7323\u20137.","journal-title":"J Med Chem"},{"issue":"15","key":"395_CR205","doi-asserted-by":"publisher","first-page":"5976","DOI":"10.1021\/ja1112996","volume":"133","author":"L Feng","year":"2011","unstructured":"Feng L, Geisselbrecht Y, Blanck S, Wilbuer A, Atilla-Gokcumen GE, Filippakopoulos P, et al. Structurally sophisticated octahedral metal complexes as highly selective protein kinase inhibitors. J Am Chem Soc. 2011;133(15):5976\u201386.","journal-title":"J Am Chem Soc"},{"issue":"12","key":"395_CR206","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.1021\/cb400407c","volume":"8","author":"DA Carlson","year":"2013","unstructured":"Carlson DA, Franke AS, Weitzel DH, Speer BL, Hughes PF, Hagerty L, et al. Fluorescence linked enzyme chemoproteomic strategy for discovery of a potent and selective DAPK1 and ZIPK inhibitor. ACS Chem Biol. 2013;8(12):2715\u201323.","journal-title":"ACS Chem Biol"},{"key":"395_CR207","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jmgm.2017.08.001","volume":"77","author":"P Singh","year":"2017","unstructured":"Singh P, Talwar P. Exploring putative inhibitors of Death Associated Protein Kinase 1 (DAPK1) via targeting Gly-Glu-Leu (GEL) and Pro-Glu-Asn (PEN) substrate recognition motifs. J Mol Graph Model. 2017;77:153\u201367.","journal-title":"J Mol Graph Model"},{"key":"395_CR208","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.ejmech.2018.10.057","volume":"162","author":"AK Farag","year":"2019","unstructured":"Farag AK, Hassan AHE, Jeong H, Kwon Y, Choi JG, Oh MS, et al. First-in-class DAPK1\/CSF1R dual inhibitors: discovery of 3,5-dimethoxy-N-(4-(4-methoxyphenoxy)-2-((6-morpholinopyridin-3-yl)amino)pyrimidin-5-yl)benzamide as a potential anti-tauopathies agent. Eur J Med Chem. 2019;162:161\u201375.","journal-title":"Eur J Med Chem"},{"issue":"9","key":"395_CR209","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.3390\/ph15091050","volume":"15","author":"A Elkamhawy","year":"2022","unstructured":"Elkamhawy A, Paik S, Ali EMH, Hassan AHE, Kang SJ, Lee K, et al. Identification of novel aryl carboxamide derivatives as death-associated protein kinase 1 (DAPK1) inhibitors with anti-proliferative activities: design, synthesis, in vitro, and in silico biological studies. Pharmaceuticals (Basel). 2022;15(9):1050.","journal-title":"Pharmaceuticals (Basel)"},{"issue":"18","key":"395_CR210","doi-asserted-by":"publisher","first-page":"5224","DOI":"10.1039\/C5OB00230C","volume":"13","author":"MJ de Pineda","year":"2015","unstructured":"de Pineda MJ, Torres-Rusillo S, Unciti-Broceta JD, Fernandez-Rubio P, Luque-Gonzalez MA, Gallo MA, et al. Synthesis of 6,8,9 poly-substituted purine analogue libraries as pro-apoptotic inducers of human leukemic lymphocytes and DAPK-1 inhibitors. Org Biomol Chem. 2015;13(18):5224\u201334.","journal-title":"Org Biomol Chem"},{"issue":"1","key":"395_CR211","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1002\/cbic.201402512","volume":"16","author":"TS Wilbek","year":"2015","unstructured":"Wilbek TS, Skovgaard T, Sorrell FJ, Knapp S, Berthelsen J, Stromgaard K. Identification and characterization of a small-molecule inhibitor of death-associated protein kinase 1. ChemBioChem. 2015;16(1):59\u201363.","journal-title":"ChemBioChem"},{"key":"395_CR212","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2023.2227720","author":"A Firoz","year":"2023","unstructured":"Firoz A, Talwar P. Role of death-associated protein kinase 1 (DAPK1) in retinal degenerative diseases: an in-silico approach towards therapeutic intervention. J Biomol Struct Dyn. 2023. https:\/\/doi.org\/10.1080\/07391102.2023.2227720.","journal-title":"J Biomol Struct Dyn"},{"issue":"8","key":"395_CR213","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1007\/s11064-022-03628-7","volume":"47","author":"T Noori","year":"2022","unstructured":"Noori T, Shirooie S, Sureda A, Sobarzo-Sanchez E, Dehpour AR, Saldias M, et al. Regulation of DAPK1 by natural products: an important target in treatment of stroke. Neurochem Res. 2022;47(8):2142\u201357.","journal-title":"Neurochem Res"},{"issue":"18","key":"395_CR214","doi-asserted-by":"publisher","first-page":"7400","DOI":"10.1021\/acs.jmedchem.5b00893","volume":"58","author":"T Yokoyama","year":"2015","unstructured":"Yokoyama T, Kosaka Y, Mizuguchi M. Structural insight into the interactions between death-associated protein kinase 1 and natural flavonoids. J Med Chem. 2015;58(18):7400\u20138.","journal-title":"J Med Chem"},{"issue":"Pt 1","key":"395_CR215","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1107\/S2052252520015614","volume":"8","author":"T Yokoyama","year":"2021","unstructured":"Yokoyama T, Suzuki R, Mizuguchi M. Crystal structure of death-associated protein kinase 1 in complex with the dietary compound resveratrol. IUCrJ. 2021;8(Pt 1):131\u20138.","journal-title":"IUCrJ"},{"key":"395_CR216","doi-asserted-by":"publisher","DOI":"10.1111\/febs.16817","author":"T Yokoyama","year":"2023","unstructured":"Yokoyama T, Kusaka K. Characterization of the molecular interactions between resveratrol derivatives and death-associated protein kinase 1. FEBS J. 2023. https:\/\/doi.org\/10.1111\/febs.16817.","journal-title":"FEBS J"},{"issue":"Pt 5","key":"395_CR217","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1107\/S2059798320003940","volume":"76","author":"T Yokoyama","year":"2020","unstructured":"Yokoyama T, Wijaya P, Kosaka Y, Mizuguchi M. Structural and thermodynamic analyses of interactions between death-associated protein kinase 1 and anthraquinones. Acta Crystallogr D Struct Biol. 2020;76(Pt 5):438\u201346.","journal-title":"Acta Crystallogr D Struct Biol"},{"key":"395_CR218","doi-asserted-by":"publisher","DOI":"10.1007\/s12033-023-00744-9","author":"P Talwar","year":"2023","unstructured":"Talwar P, Singh P, Ravanan P. Structure-based virtual screening and discovery of new bi-functional DAPK1 inhibitors. Mol Biotechnol. 2023. https:\/\/doi.org\/10.1007\/s12033-023-00744-9.","journal-title":"Mol Biotechnol"},{"key":"395_CR219","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2020.589588","volume":"12","author":"P Qi","year":"2020","unstructured":"Qi P, Li J, Gao S, Yuan Y, Sun Y, Liu N, et al. Network pharmacology-based and experimental identification of the effects of quercetin on Alzheimer\u2019s Disease. Front Aging Neurosci. 2020;12: 589588.","journal-title":"Front Aging Neurosci"},{"issue":"4","key":"395_CR220","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1002\/mco2.281","volume":"4","author":"H Chang","year":"2023","unstructured":"Chang H, Hou J, Shao Y, Xu M, Weng X, Du Y, et al. Sanggenon C inhibits cell proliferation and induces apoptosis by regulating the MIB1\/DAPK1 axis in glioblastoma. MedComm. 2023;4(4):281.","journal-title":"MedComm"},{"issue":"2","key":"395_CR221","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.ejca.2010.09.021","volume":"47","author":"XJ Luo","year":"2011","unstructured":"Luo XJ, Li LL, Deng QP, Yu XF, Yang LF, Luo FJ, et al. Grifolin, a potent antitumour natural product upregulates death-associated protein kinase 1 DAPK1 via p53 in nasopharyngeal carcinoma cells. Eur J Cancer. 2011;47(2):316\u201325.","journal-title":"Eur J Cancer"},{"issue":"1","key":"395_CR222","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.bbrc.2013.03.063","volume":"434","author":"B Wu","year":"2013","unstructured":"Wu B, Yao H, Wang S, Xu R. DAPK1 modulates a curcumin-induced G2\/M arrest and apoptosis by regulating STAT3, NF-kappaB, and caspase-3 activation. Biochem Biophys Res Commun. 2013;434(1):75\u201380.","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"395_CR223","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.npep.2011.03.001","volume":"45","author":"L Malavolta","year":"2011","unstructured":"Malavolta L, Cabral FR. Peptides: important tools for the treatment of central nervous system disorders. Neuropeptides. 2011;45(5):309\u201316.","journal-title":"Neuropeptides"},{"issue":"1","key":"395_CR224","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/cbdd.12055","volume":"81","author":"DJ Craik","year":"2013","unstructured":"Craik DJ, Fairlie DP, Liras S, Price D. The future of peptide-based drugs. Chem Biol Drug Des. 2013;81(1):136\u201347.","journal-title":"Chem Biol Drug Des"},{"issue":"9","key":"395_CR225","doi-asserted-by":"publisher","first-page":"656","DOI":"10.2174\/1389203722666210920151810","volume":"22","author":"A Yadav","year":"2021","unstructured":"Yadav A, Pandey D, Ashraf GM. Peptide based therapy for neurological disorders. Curr Protein Pept Sci. 2021;22(9):656\u201365.","journal-title":"Curr Protein Pept Sci"},{"issue":"1","key":"395_CR226","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s41392-022-00904-4","volume":"7","author":"L Wang","year":"2022","unstructured":"Wang L, Wang N, Zhang W, Cheng X, Yan Z, Shao G, et al. Therapeutic peptides: current applications and future directions. Signal Transduct Target Ther. 2022;7(1):48.","journal-title":"Signal Transduct Target Ther"},{"key":"395_CR227","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2023.115817","volume":"261","author":"Z Li","year":"2023","unstructured":"Li Z, Yin B, Zhang S, Lan Z, Zhang L. Targeting protein kinases for the treatment of Alzheimer\u2019s disease: recent progress and future perspectives. Eur J Med Chem. 2023;261: 115817.","journal-title":"Eur J Med Chem"},{"issue":"1","key":"395_CR228","doi-asserted-by":"publisher","DOI":"10.1002\/trc2.12044","volume":"6","author":"F Fagiani","year":"2020","unstructured":"Fagiani F, Lanni C, Racchi M, Govoni S. Targeting dementias through cancer kinases inhibition. Alzheimers Dement (N Y). 2020;6(1): e12044.","journal-title":"Alzheimers Dement (N Y)"},{"issue":"5","key":"395_CR229","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1192\/bjp.2019.76","volume":"215","author":"OV Forlenza","year":"2019","unstructured":"Forlenza OV, Radanovic M, Talib LL, Gattaz WF. Clinical and biological effects of long-term lithium treatment in older adults with amnestic mild cognitive impairment: randomised clinical trial. Br J Psychiatry. 2019;215(5):668\u201374.","journal-title":"Br J Psychiatry"},{"issue":"5","key":"395_CR230","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1192\/bjp.bp.110.080044","volume":"198","author":"OV Forlenza","year":"2011","unstructured":"Forlenza OV, Diniz BS, Radanovic M, Santos FS, Talib LL, Gattaz WF. Disease-modifying properties of long-term lithium treatment for amnestic mild cognitive impairment: randomised controlled trial. Br J Psychiatry. 2011;198(5):351\u20136.","journal-title":"Br J Psychiatry"},{"issue":"1","key":"395_CR231","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3233\/JAD-141959","volume":"45","author":"S Lovestone","year":"2015","unstructured":"Lovestone S, Boada M, Dubois B, Hull M, Rinne JO, Huppertz HJ, et al. A phase II trial of tideglusib in Alzheimer\u2019s disease. J Alzheimers Dis. 2015;45(1):75\u201388.","journal-title":"J Alzheimers Dis"},{"key":"395_CR232","doi-asserted-by":"publisher","first-page":"189","DOI":"10.3389\/fncel.2013.00189","volume":"7","author":"V Tell","year":"2013","unstructured":"Tell V, Hilgeroth A. Recent developments of protein kinase inhibitors as potential AD therapeutics. Front Cell Neurosci. 2013;7:189.","journal-title":"Front Cell Neurosci"},{"key":"395_CR233","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2022.101593","volume":"76","author":"ZA Khan","year":"2022","unstructured":"Khan ZA, Sumsuzzman DM, Choi J, Hong Y. Neurodegenerative effect of DAPK1 after cerebral hypoxia-ischemia is associated with its post-transcriptional and signal transduction regulations: A systematic review and meta-analysis. Ageing Res Rev. 2022;76: 101593.","journal-title":"Ageing Res Rev"},{"issue":"13","key":"395_CR234","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.3390\/ijms20133131","volume":"20","author":"N Kim","year":"2019","unstructured":"Kim N, Chen D, Zhou XZ, Lee TH. Death-associated protein kinase 1 phosphorylation in neuronal cell death and neurodegenerative disease. Int J Mol Sci. 2019;20(13):3131.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"395_CR235","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/s41419-020-2534-9","volume":"11","author":"YH Wu","year":"2020","unstructured":"Wu YH, Chou TF, Young L, Hsieh FY, Pan HY, Mo ST, et al. Tumor suppressor death-associated protein kinase 1 inhibits necroptosis by p38 MAPK activation. Cell Death Dis. 2020;11(5):305.","journal-title":"Cell Death Dis"}],"container-title":["Translational Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40035-023-00395-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40035-023-00395-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40035-023-00395-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T03:08:25Z","timestamp":1704769705000},"score":1,"resource":{"primary":{"URL":"https:\/\/translationalneurodegeneration.biomedcentral.com\/articles\/10.1186\/s40035-023-00395-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,9]]},"references-count":235,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["395"],"URL":"https:\/\/doi.org\/10.1186\/s40035-023-00395-5","relation":{},"ISSN":["2047-9158"],"issn-type":[{"value":"2047-9158","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,9]]},"assertion":[{"value":"4 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"B.M. Kim is a founder of and own equity in AgingTarget Inc. Other authors do not have any competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4"}}